Drugs / AZD6423
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01926366 | Sep 2013 → Mar 2014 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD6423 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01926366 ↗ |
| Route | Intravenous | “AZD6423 or placebo will be administered IV” NCT01926366 ↗ |